NOTES: Track and field bests are compiled from results sent to the Sun-Gazette. Only top 8 listed for each event for Class AA and Class AAA. Only one relay team per school listed. All area coaches are ...

All of the results and scores from the first two days of the singles tennis state championships at Bates College in Lewiston. Saturday's semifinals and finals have been moved to Colby College in ...

Results from the North Jersey, Section 2, Groups 1 and 4 sectional track and field meet on 5/16/2025 and 5/17/2025 ...

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

When I stopped attending my Latter-day Saint ward in 2014, I never really had any intention of going through the formal process of coordinating with corporate to cancel my relationship with God.

Eagles cornerback Eli Ricks stirred controversy during the team's White House visit by publicly expressing his admiration for Ivanka Trump on social media. His tweets, complimenting her appearance ...

In JPMorgan's view, CVS's move "will likely impact only a small portion of Eli Lilly's Zepbound business," and the bank therefore believes Lilly stock will still outperform the market. Investment ...

Eli Lilly said the revision reflects a $1.57 billion deal charge recorded in the first quarter, which is primarily related to its acquisition of a certain oral cancer drug from Scorpion Therapeutics.

Eli Lilly (NYSE: NYSE:LLY) is set to report its first-quarter earnings on Thursday, May 1st, before the market opens. Analysts expect the drugmaker to earn $3.46 (+34.1% Y/Y) on revenue of $12.72B ...

Positive results for Eli Lilly's new diabetes and weight-loss drug have recently boosted its stock price. Data from several studies on the GLP-1 drug are expected to come out this year.

Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting results tomorrow before market hours. Here’s what to look for. Eli Lilly met analysts’ revenue expectations last quarter ...